SAB Biotherapeutics, Inc. Balance Sheet

Balance Sheet Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Accumulated Depreciation 1.77M3.22M6.28M9.91M14.57M
Receivables - Accured 0.06M
Assets
Assets 56.54M81.14M50.90M83.94M44.20M
Current Assets
Cash & Equivalents 12.61M33.21M15.05M56.57M8.90M
Receivables - Net 20.57M8.01M5.56M
Receivables - Other 0.01M0.01M
Receivables 20.58M8.02M5.56M
Prepaid Assets 1.28M2.64M1.49M2.34M2.98M
Current Assets 34.46M50.19M22.10M58.91M23.79M
Non-Current Assets
Construction in Progress 4.61M0.31M
Property, Plant & Equipment (Net) 14.85M24.31M23.25M19.74M15.37M
Other Non-Current Assets 0.24M13.10M
Non-Current Assets 22.08M30.95M28.81M25.03M20.40M
Liabilities
Current Liabilities
Accounts Payables 7.38M12.46M9.92M6.69M5.47M
Notes Payables 0.71M1.80M0.77M1.05M0.28M
Payables 8.09M14.25M10.69M7.74M5.75M
Accumulated Expenses 0.44M0.67M0.51M3.40M4.17M
Other Accumulated Expenses 0.09M0.28M0.51M0.48M0.52M
Current Leases 0.92M1.14M0.49M0.67M0.39M
Current Deferred Revenue 0.10M0.10M1.32M
Total Current Liabilities 11.06M26.46M14.99M10.81M7.98M
Non-Current Liabilities
Capital Leases 3.92M3.76M3.63M3.42M3.28M
Non-Current Debt 0.17M0.54M
Convertible Debt 0.54M
Operating Leases 2.37M2.80M0.36M0.64M0.58M
Other Non-Current Liabilities 10.72M0.32M11.77M6.39M
Total Non-Current Liabilities 31.87M19.53M14.87M11.84M
Liabilities
Total Liabilities 17.53M42.59M19.85M26.64M18.23M
Shareholder's Equity
Total Debt 0.17M0.54M
Common Equity 39.01M38.55M31.06M57.30M25.97M
Shareholder's Equity 39.01M38.55M31.06M57.30M25.97M
Liabilities and Shareholders Equity 56.54M81.14M50.90M83.94M44.20M
Treasury Shares 0.05M-0.05M0.05M
Retained Earnings -11.98M-29.13M-47.87M-90.06M-124.17M
Preferred Shares 0.00M0.00M
Shares Outstanding 25.97M4.35M5.09M9.28M9.34M